Teresa L. Kline Insider Profile
4 Followers
Teresa L. Kline, Director at Intersect ENT, holds 85.32K shares in Accendra Health (Ticker: ACH), holds 0.00 shares in Amedisys (Ticker: AMED), holds 0.00 shares in Intersect ENT (Ticker: XENT).
Teresa L. Kline Intersect ENT (XENT)Director
Intersect ENT (XENT)
Director
Not Ranked
Teresa L. Kline has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Roles
Director
Roles that Teresa L. Kline holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Teresa L. Kline
Teresa L. Kline's Trading History
Intersect ENT
May 16, 2022
―
Uninformative Sell
249.65K
$0.00
Amedisys
Aug 14, 2025
―
Uninformative Sell
―
$0.00
Apria
―
―
―
―
Accendra Health
May 18, 2026
Director
Uninformative Buy
―
$217.56K
List of latest transactions for each holding click on a transaction to see Teresa L. Kline's performance on stock
You May Also Like
Teresa L. Kline insider profile FAQ
What is the percentage of profitable transactions made by Teresa L. Kline?
The percentage of profitable transactions made by Teresa L. Kline is ―.
What is the average return per transaction made by Teresa L. Kline?
The average return per transaction made by Teresa L. Kline is ―.
What stocks does Teresa L. Kline hold?
Teresa L. Kline holds: XENT, AMED, APR, ACH stocks.
What was Teresa L. Kline’s latest transaction?
Teresa L. Kline latest transaction was an Uninformative Buy of ―.
What was Teresa L. Kline's most profitable transaction?
Teresa L. Kline’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Teresa L. Kline's role in Intersect ENT?
Teresa L. Kline's role in Intersect ENT is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.